China has pledged $3.49 million to support HIV prevention services in South Africa over the next two years under a new ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
A man accused of deliberately infecting seven young men with HIV could be the "nicest person going" but also had a "little ...
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...
Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
China pledges $3.5m for HIV prevention in South Africa.US cuts left $400m gap; South Africa funds 83% of program.Support ...
China will finance HIV-prevention programs in South Africa for the first time, taking a small step into the massive void left by US funding cuts earlier this year.
The Star Worldwide (English) on MSN
How Kenya’s HIV Care System Is Buckling Under Donor Withdrawal
Over the past decade, Kenya has been a global beacon, celebrated for achieving near-universal access to life-saving HIV treatment ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results